S

Sunzen Biotech Bhd
KLSE:SUNZEN

Watchlist Manager
Sunzen Biotech Bhd
KLSE:SUNZEN
Watchlist
Price: 0.31 MYR
Market Cap: 249.5m MYR
Have any thoughts about
Sunzen Biotech Bhd?
Write Note

Net Margin
Sunzen Biotech Bhd

6.3%
Current
2%
Average
3.3%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
6.3%
=
Net Income
9m
/
Revenue
142.7m

Net Margin Across Competitors

Country MY
Market Cap 249.5m MYR
Net Margin
6%
Country FR
Market Cap 181.7B EUR
Net Margin
15%
Country UK
Market Cap 114.1B GBP
Net Margin
11%
Country IN
Market Cap 5.5T INR
Net Margin
17%
Country UK
Market Cap 34.9B GBP
Net Margin
11%
Country DE
Market Cap 27.8B EUR
Net Margin
8%
Country US
Market Cap 27B USD
Net Margin
1%
Country JP
Market Cap 3T JPY
Net Margin
5%
Country IN
Market Cap 1.1T INR
Net Margin
-3%
Country IN
Market Cap 903.7B INR
Net Margin
14%
Country US
Market Cap 9.9B USD
Net Margin
12%
No Stocks Found

Sunzen Biotech Bhd
Glance View

Market Cap
249.5m MYR
Industry
Consumer products

Sunzen Biotech Bhd.is an investment holding company, which engages in biotechnology research and development, and the manufacture and marketing of animal feed supplement products. The company is headquartered in Shah Alam, Selangor. The company went IPO on 2008-10-08. Its segments include Manufacturing and trading of animal health products (AH), Trading of crude palm oil products (CPO), Traditional Chinese medicines, herbal foods and beverages, bird's nest (TCM) and Loan financing. The company specializes in animal health and nutrition, manufactures and markets a range of related products for both livestock and companion animals. The company is also involved in the palm oil trading business, which entails the trading of crude palm oil and its derivative products. Its product categories include feed additive, oral pump, functional red palm oil, injectables, water soluble, detergent and disinfection and premix. Its animal health products are offered to domestic and overseas markets in countries, such as China, Korea and the Middle East.

SUNZEN Intrinsic Value
0.22 MYR
Overvaluation 28%
Intrinsic Value
Price
S

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
6.3%
=
Net Income
9m
/
Revenue
142.7m
What is the Net Margin of Sunzen Biotech Bhd?

Based on Sunzen Biotech Bhd's most recent financial statements, the company has Net Margin of 6.3%.